Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 1	2026-07-07		NCT06792734

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bantam Pharmaceuticals	2

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Levine Cancer Institute, Atrium Health	Charlotte	United States	1
MD Anderson Cancer Center	Houston	United States	589

Clinical trials